CITIUS PHARMACEUTICALS INC's ticker is and the CUSIP is 17322U957. A total of 3 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26 | -42.2% | 38,200 | 0.0% | 0.00% | – |
Q2 2023 | $45 | 0.0% | 38,200 | -1.0% | 0.00% | – |
Q1 2023 | $45 | +36.4% | 38,600 | -9.8% | 0.00% | – |
Q4 2022 | $33 | -99.9% | 42,800 | +9.2% | 0.00% | – |
Q3 2022 | $47,000 | +51.6% | 39,200 | +15.6% | 0.00% | – |
Q2 2022 | $31,000 | -44.6% | 33,900 | +8.3% | 0.00% | – |
Q1 2022 | $56,000 | – | 31,300 | +5116.7% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 600 | -98.2% | 0.00% | – |
Q3 2021 | $88,000 | – | 34,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 491 | $100,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 34,200 | $88,000 | 0.00% |